FDA.reportPublic FDA data

Application 220200

Type
NDA
Sponsor
AVYXA HOLDINGS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AVOPEFETOPOSIDESOLUTION;INTRAVENOUS100MG/5ML (20MG/ML)YesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85136ORIG 2026-02-24
85055ORIG 2026-02-18